Concord Biotech Ltd. Conference Calls and Earnings Call Transcripts

Concord Biotech Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

announcement
Conference/Earnings Calls Alerts
Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
In Continuation of our letter dated February 09, 2024 regarding audio recording of the unaudited (Standalone and Consolidated) financial results of the company for the Third Quarter and Nine months ended December 31, 2023 , transcripts of the earnings call for the said period enclosed herewith and available on the website of the company at the following link after sending this letter to you, https://www.concordbiotech.com/investors
Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated January 31, 2024 to the Stock exchanges regarding Earning call in respect of the Unaudited (Standalone and Consolidated) Financial Results of the company for the Third Quarter and Nine Months ended December 31, 2023, we wish to inform that the said Earning Call was held today at 02:00 PM (IST). The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :- https://www.concordbiotech.com/public/assets/pdf/q3fy24-earnings-audio-20240209175243.mp3 Kindly take the above on records.
Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
In Continuation of our letter dated November 09, 2023 regarding audio recording of the Unaudited (Standalone and consolidated) Financial results of the company for the quarter and half year ended September 30, 2023, Earnings call for investors and analysts and pursuant to regulation 30(6) of SEBI LODR, the transcripts of the earning call for the said period enclosed herewith.
Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated October 31, 2023 to the Stock exchanges regarding Earning call in respect of the Unaudited (Standalone and Consolidated) Financial Results of the company for the Quarter and half year ended September 30, 2023, we wish to inform that the said Earning Call was held today at 03:00 PM (IST). The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :- https://www.concordbiotech.com/public/assets/pdf/Q2FY24-Earnings-call-audio.mp3 Kindly take the above on records
Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, and further to our intimation dated September 01, 2023 to the exchange regarding Earning call in respect of the Unaudited Financial Results of the company for the Quarter ended June 30, 2023, we wish to inform that the said Earning Call was held today at 4:00 PM (IST). The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :- https://www.concordbiotech.com/public/assets/pdf/Q1FY24-Earnings-call.mpeg Kindly take the above on records.

Earnings Calls Podcast on